BioMrieux Pink Sheet Forward View

BMXMF Stock  USD 112.57  1.47  1.32%   
BioMrieux Pink Sheet outlook is based on your current time horizon. We suggest always using this module together with an analysis of BioMrieux's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 11th of February 2026 the relative strength index (rsi) of BioMrieux's share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of BioMrieux's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of BioMrieux and does not consider all of the tangible or intangible factors available from BioMrieux's fundamental data. We analyze noise-free headlines and recent hype associated with bioMrieux SA, which may create opportunities for some arbitrage if properly timed.
Using BioMrieux hype-based prediction, you can estimate the value of bioMrieux SA from the perspective of BioMrieux response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of bioMrieux SA on the next trading day is expected to be 110.57 with a mean absolute deviation of 1.78 and the sum of the absolute errors of 108.48.

BioMrieux after-hype prediction price

    
  USD 112.93  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Historical Fundamental Analysis of BioMrieux to cross-verify your projections.

BioMrieux Additional Predictive Modules

Most predictive techniques to examine BioMrieux price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BioMrieux using various technical indicators. When you analyze BioMrieux charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A naive forecasting model for BioMrieux is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of bioMrieux SA value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

BioMrieux Naive Prediction Price Forecast For the 12th of February 2026

Given 90 days horizon, the Naive Prediction forecasted value of bioMrieux SA on the next trading day is expected to be 110.57 with a mean absolute deviation of 1.78, mean absolute percentage error of 4.95, and the sum of the absolute errors of 108.48.
Please note that although there have been many attempts to predict BioMrieux Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BioMrieux's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

BioMrieux Pink Sheet Forecast Pattern

Backtest BioMrieux  BioMrieux Price Prediction  Research Analysis  

BioMrieux Forecasted Value

In the context of forecasting BioMrieux's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. BioMrieux's downside and upside margins for the forecasting period are 108.66 and 112.48, respectively. We have considered BioMrieux's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
112.57
108.66
Downside
110.57
Expected Value
112.48
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of BioMrieux pink sheet data series using in forecasting. Note that when a statistical model is used to represent BioMrieux pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria119.7103
BiasArithmetic mean of the errors None
MADMean absolute deviation1.7783
MAPEMean absolute percentage error0.0145
SAESum of the absolute errors108.4787
This model is not at all useful as a medium-long range forecasting tool of bioMrieux SA. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict BioMrieux. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for BioMrieux

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as bioMrieux SA. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
111.02112.93114.84
Details
Intrinsic
Valuation
LowRealHigh
103.54105.45123.83
Details

BioMrieux After-Hype Price Density Analysis

As far as predicting the price of BioMrieux at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in BioMrieux or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of BioMrieux, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

BioMrieux Estimiated After-Hype Price Volatility

In the context of predicting BioMrieux's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on BioMrieux's historical news coverage. BioMrieux's after-hype downside and upside margins for the prediction period are 111.02 and 114.84, respectively. We have considered BioMrieux's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
112.57
111.02
Downside
112.93
After-hype Price
114.84
Upside
BioMrieux is very steady at this time. Analysis and calculation of next after-hype price of bioMrieux SA is based on 3 months time horizon.

BioMrieux Pink Sheet Price Outlook Analysis

Have you ever been surprised when a price of a Company such as BioMrieux is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BioMrieux backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BioMrieux, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.21 
1.91
  0.36 
  0.04 
36 Events / Month
11 Events / Month
In about 36 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
112.57
112.93
0.32 
110.40  
Notes

BioMrieux Hype Timeline

bioMrieux SA is currently traded for 112.57. The entity has historical hype elasticity of 0.36, and average elasticity to hype of competition of 0.04. BioMrieux is expected to increase in value after the next headline, with the price projected to jump to 112.93 or above. The average volatility of media hype impact on the company the price is about 110.4%. The price rise on the next news is estimated to be 0.32%, whereas the daily expected return is currently at -0.21%. The volatility of related hype on BioMrieux is about 989.94%, with the expected price after the next announcement by competition of 112.61. The company reported the revenue of 3.38 B. Net Income was 601.1 M with profit before overhead, payroll, taxes, and interest of 1.96 B. Assuming the 90 days horizon the next expected press release will be in about 36 days.
Check out Historical Fundamental Analysis of BioMrieux to cross-verify your projections.

BioMrieux Related Hype Analysis

Having access to credible news sources related to BioMrieux's direct competition is more important than ever and may enhance your ability to predict BioMrieux's future price movements. Getting to know how BioMrieux's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how BioMrieux may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MYNZMainz Biomed BV 0.03 5 per month 0.00 (0.12) 9.48 (6.90) 23.37 
APDNApplied DNA Sciences(0.23)8 per month 6.49  0.06  15.72 (9.55) 68.08 
STIMNeuronetics(0.13)8 per month 0.00 (0.11) 10.55 (9.52) 34.69 
PREPrenetics Global(0.05)7 per month 3.65  0.16  9.77 (6.74) 22.19 
FONRFonar(0.17)10 per month 0.45  0.09  1.96 (1.98) 27.36 
IQVIQVIA Holdings(4.71)10 per month 0.00 (0.11) 3.30 (2.46) 15.97 
MTDMettler Toledo International 21.11 8 per month 0.00 (0.09) 2.51 (2.37) 7.69 
TWSTTwist Bioscience Corp 3.35 10 per month 2.84  0.16  7.70 (4.95) 17.57 
WATWaters 2.22 10 per month 0.00 (0.12) 3.25 (2.03) 18.00 
ICLRICON PLC 0.60 8 per month 0.00 (0.08) 4.70 (5.98) 16.93 
DHRDanaher(0.48)9 per month 1.40 (0.02) 2.30 (2.19) 8.05 
TMOThermo Fisher Scientific(9.91)9 per month 0.00 (0.11) 2.43 (2.29) 7.20 
CRLCharles River Laboratories(3.49)11 per month 2.04  0.02  3.93 (2.40) 14.56 
CDNACareDx Inc(0.20)9 per month 3.42  0.08  6.91 (5.05) 28.32 
GHGuardant Health 0.16 8 per month 2.51  0.03  4.16 (4.24) 17.61 
ILMNIllumina(1.57)8 per month 0.00 (0.04) 3.85 (3.26) 15.59 
AAgilent Technologies(3.25)9 per month 0.00 (0.17) 2.90 (2.58) 7.85 

Other Forecasting Options for BioMrieux

For every potential investor in BioMrieux, whether a beginner or expert, BioMrieux's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BioMrieux Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BioMrieux. Basic forecasting techniques help filter out the noise by identifying BioMrieux's price trends.

View BioMrieux Related Equities

 Risk & Return  Correlation

BioMrieux Market Strength Events

Market strength indicators help investors to evaluate how BioMrieux pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioMrieux shares will generate the highest return on investment. By undertsting and applying BioMrieux pink sheet market strength indicators, traders can identify bioMrieux SA entry and exit signals to maximize returns.

BioMrieux Risk Indicators

The analysis of BioMrieux's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BioMrieux's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biomrieux pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for BioMrieux

The number of cover stories for BioMrieux depends on current market conditions and BioMrieux's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BioMrieux is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BioMrieux's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Information on Investing in BioMrieux Pink Sheet

BioMrieux financial ratios help investors to determine whether BioMrieux Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioMrieux with respect to the benefits of owning BioMrieux security.